United States Biotechnology & Medical Research

LianBio (LIAN)

Track

Stock chart
Ticker: LIAN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Wang Yizhe
Officer; OFFICER FORMER CEO
1 sale — total 3,419,400 USD
Proposed sale 8 Jan 2024
Value US$621,054.32 | Price 30.56 | Shares 83,575
Sale 2 Jan 2024
Value US$2,414,098.57 | Price 393.91 | Shares 57,900
Proposed sale 29 Dec 2023
Value US$1,107,500.00 | Price 4.43 | Shares 250,000
Sale 3 Jan 2023
Value US$3,701.51 | Price 1.65 | Shares 2,239
Buy 18 Aug 2022
Value US$2,395,776.00 | Price 2.40 | Shares 998,240
Buy 26 May 2022
Value US$215,970.00 | Price 3.13 | Shares 69,000
Buy 25 May 2022
Value US$315,600.00 | Price 2.63 | Shares 120,000
Buy 24 May 2022
Value US$105,100.97 | Price 2.47 | Shares 42,551
Buy 23 May 2022
Value US$21,663.00 | Price 2.49 | Shares 8,700
Buy 3 Nov 2021
Value US$270,200.00 | Price 13.51 | Shares 20,000
Buy 3 Nov 2021
Value US$36,000,000.00 | Price 16.00 | Shares 2,250,000
Buy 2 Nov 2021
Value US$1,350,000.00 | Price 13.50 | Shares 100,000
Buy 1 Nov 2021
Value US$1,860,000.00 | Price 15.50 | Shares 120,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-08 2024-01-08 PrS Proposed sale
Wang Yizhe

Officer; OFFICER FORMER CEO

Officer
83,575
30.56
US$621,054 		83,575 30.56 US$621,054
2024-04-11 2024-01-02 S Sale
Gu Ehong

Interim CFO

Officer
57,900 +23.4%
393.91
US$2,414,099 		57,900 +23.4% 393.91 US$2,414,099
2023-12-29 2023-12-29 PrS Proposed sale
Wang Yizhe

Officer; FORMER CEO

Officer
89,365
135.79
US$3,444,007 		89,365 135.79 US$3,444,007
2023-01-05 2023-01-03 S Sale
0.6
QIAN JIANG

SVP, China General Manager

Officer
2,239 -3.2%
1.65
US$3,702 		2,239 -3.2% 1.65 US$3,702
2022-08-22 2022-08-18 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
998,240 +36.6%
2.40
US$2,395,776 		998,240 +36.6% 2.40 US$2,395,776
2022-05-27 2022-05-26 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
69,000 +2.6%
3.13
US$215,970 		69,000 +2.6% 3.13 US$215,970
2022-05-25 2022-05-25 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
120,000 +4.7%
2.63
US$315,600 		120,000 +4.7% 2.63 US$315,600
2022-05-25 2022-05-24 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
42,551 +1.7%
2.47
US$105,101 		42,551 +1.7% 2.47 US$105,101
2022-05-25 2022-05-23 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
8,700 +0.3%
2.49
US$21,663 		8,700 +0.3% 2.49 US$21,663
2021-11-05 2021-11-03 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
20,000 +0.1%
13.51
US$270,200 		20,000 +0.1% 13.51 US$270,200
2021-11-05 2021-11-03 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
2,250,000 +8.8%
16.00
US$36,000,000 		2,250,000 +8.8% 16.00 US$36,000,000
2021-11-03 2021-11-02 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
100,000 +1.4%
13.50
US$1,350,000 		100,000 +1.4% 13.50 US$1,350,000
2021-11-03 2021-11-01 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
120,000 +1.7%
15.50
US$1,860,000 		120,000 +1.7% 15.50 US$1,860,000
Explore more

More insider trading research around LianBio

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America